Inaccurate cancer tests may have contributed to the deaths of two people and thousands must be retested after a North Wales doctor misread test results.
Approximately 4,500 people need retesting after a clinical examination of cancer tests given by Dr. Roger Williams discovered 12 questionable results -- two which belonged to two dead patients, The Daily Telegraph reported Thursday.
Three people who Williams, 64, told were cancer-free have begun treatment for the disease. He reportedly resigned from his job as a part-time clinician after the errors were found.
People tested by Williams as far back as 2004 are set for re-examination.
"The errors initially identified three patients who had been advised that their tissue samples did not give reason for concern when in fact they should have been told that they were clinically suspicious and, in some cases, actually indicative of cancer," a statement from the North East Wales NHS Trust said.
The results of the 4,500 test re-examinations will give doctors a fix on whether it is a marginal or significant problem, said Chief Executive of the Trust, Marry Burrows.
Copyright 2008 by United Press International
Related stories:
Study looks at psychological impact of gene test for breast cancer
Personal beliefs about inconclusive DNA testing for hereditary breast cancer are associated with cancer-related worry, and such beliefs are an especially strong predictor of whether women had been able to leave the period of DNA-testing behind, reports a study in the October issue of
Genetics in Medicine, official journal of the American College of Medical Genetics (ACMG). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Want a mammogram? Get in line
Doctors usually recommend that women older than 40 get yearly mammograms. But if you're planning on calling Northwestern Memorial Hospital's state-of-the-art breast imaging center, grab next year's calendar: The next opening is in May.
RNA molecules boost vaccine effectiveness
(PhysOrg.com) -- A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.
Scientists simulate gut reaction to arsenic exposure
A simulated gastrointestinal system is helping scientists test contaminated soil for its potential to harm humans. The method is likely to save time and money for people hoping to repurpose land with an industrial past.
Compassion meditation may improve physical and emotional responses to psychological stress
Data from a new study suggests that individuals who engage in compassion meditation may benefit by reductions in inflammatory and behavioral responses to stress that have been linked to depression and a number of medical illnesses. The study's findings are published online at
www.sciencedirect.com and in the medical journal
Psychoneuroendocrinology.
Study shows stool DNA testing for colorectal cancer has potential, but challenges remain
The first generation of a stool DNA test to identify early colorectal cancer has limitations, according to a Mayo Clinic-led study published in the Oct. 7, 2008, issue of
Annals of Internal Medicine. Results did not corroborate findings of an earlier multicenter study that showed stool DNA testing was more accurate than fecal blood testing for colorectal cancer detection. *
New study examines effectiveness of colorectal cancer screening tests
New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75. The results are based on patients who began screenings at age 50 and have had consistently negative screenings up to the age of 75. Lead author Ann Graham Zauber, PhD, Associate Attending Biostatistician in the Department of Epidemiology and Biostatistics at Memorial Sloan-Kettering Cancer Center and her colleagues' findings are published in the October 7, 2008 online edition of
Annals of Internal Medicine and will appear in a forthcoming issue.
Nanoscopic screening process to speed drug discovery
Researchers at Wake Forest University are using nanotechnology to search for new cancer-fighting drugs through a process that could be up to 10,000 times faster than current methods.